The wide-ranging clinical implications of the short telomere syndromes

Internal Medicine Journal

Volumn 46, Issue 4, 2016, Pages 393-403

  Barbaro, P M ^a,b   Ziegler, D S ^a,c   Reddel, R R ^b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Aplastic; Cirrhosis; Dyskeratosis Congenita; Pulmonary fibrosis; Telomere

Indexed keywords

TELOMERASE;

BONE MARROW BIOPSY; BONE MARROW DEPRESSION; CHROMOSOME DISORDER; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSKERATOSIS CONGENITA; ESSENTIAL GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SHORT TELOMERE SYNDROME; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; AUSTRALIA; GENETICS; METABOLISM; ORGANIZATION; PHYSIOLOGY; SYNDROME; TRENDS;

AUSTRALIA; CONGRESSES AS TOPIC; DYSKERATOSIS CONGENITA; HUMANS; SYNDROME; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84962859676     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12868     Document Type: Review

References (57)

1. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-73.
2. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet 2012; 13: 693-704.
3. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD etal. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 1988; 85: 6622-6.
4. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev 2008; 88: 557-79.
5. Makarov VL, Hirose Y, Langmore JP. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 1997; 88: 657-66.
6. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H etal. Mammalian telomeres end in a large duplex loop. Cell 1999; 97: 503-14.
7. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-60.
8. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405-13.
9. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein composition of catalytically active human telomerase from immortal cells. Science 2007; 315: 1850-53.
10. Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD etal. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 2009; 323: 644-8.
11. Nandakumar J, Bell CF, Weidenfeld I, Zaug AJ, Leinwand LA, Cech TR. The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature 2012; 492: 285-9.
12. Tummala H, Walne A, Collopy L, Cardoso S, de la Fuente J, Lawson S etal. Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. J Clin Invest 2015; 125: 2151-60.
13. Wang F, Stewart JA, Kasbek C, Zhao Y, Wright WE, Price CM. Human CST has independent functions during telomere duplex replication and C-strand fill-in. Cell Rep 2012; 2: 1096-1103.
14. Vannier JB, Pavicic-Kaltenbrunner V, Petalcorin MI, Ding H, Boulton SJ. RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 2012; 149: 795-806.
15. Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol 2013; 6: 327-7.
16. Vulliamy TJ, Knight SW, Mason PJ, Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001; 27: 353-7.
17. Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I. Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol 1998; 103: 990-6.
18. Vulliamy T, Dokal I. Dyskeratosis congenita. Semin Hematol 2006; 43: 157-66.
19. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010; 24: 101-22.
20. Atkinson JC, Harvey KE, Domingo DL, Trujillo MI, Guadagnini JP, Gollins S et al. Oral and dental phenotype of dyskeratosis congenita. Oral Dis 2008; 14: 419-27.
21. Dokal I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program 2011; 2011: 480-6.
22. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood 2009; 113: 6549-7.
23. Giri N, Lee R, Faro A, Huddleston CB, White FV, Alter BP etal. Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: case report and systematic literature review. BMC Blood Disord 2011; 11: 3.
24. Alter BP, Giri N, Savage SA, Quint WG, de Koning MN, Schiffman M. Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. Int J Cancer 2013; 133: 1513-5.
25. Calado RT, Regal JA, Kleiner DE, Schrump DS, Peterson NR, Pons V etal. A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS ONE 2009; 4: e7926.
26. Hreidarsson S, Kristjansson K, Johannesson G, Johannsson JH. A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr Scand 1988; 77: 773-5.
27. Revesz T, Fletcher S, al-Gazali LI, DeBuse P. Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? J Med Genet 1992; 29: 673-5.
28. Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica 2012; 97: 353-9.
29. Pignolo RJ, Suda RK, McMillan EA, Shen J, Lee SH, Choi Y etal. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell 2008; 7: 23-31.
30. Kalb RE, Grossman ME, Hutt C. Avascular necrosis of bone in dyskeratosis congenita. Am J Med 1986; 80: 511-3.
31. Kocak H, Ballew BJ, Bisht K, Eggebeen R, Hicks BD, Suman S etal. Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev 2014; 28: 2090-102.
32. Guo Y, Kartawinata M, Li J, Pickett HA, Teo J, Kilo T etal. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood 2014; 124: 2767-4.
33. Stuart BD, Choi J, Zaidi S, Xing C, Holohan B, Chen R etal. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet 2015; 47: 512-7.
34. Calado RT, Brudno J, Mehta P, Kovacs JJ, Wu C, Zago MA etal. Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology 2011; 53: 1600-7.
35. Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica 2011; 96: 1536-42.
36. Mason PJ, Bessler M. The genetics of dyskeratosis congenita. Cancer Genet 2011; 204: 635-45.
37. Townsley DM, Dumitriu B, Young NS. Bone marrow failure and the telomeropathies. Blood 2014; 124: 2775-83.
38. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ etal. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32-8.
39. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ etal. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001; 413: 432-5.
40. Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis 2005; 34: 257-63.
41. Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet 2008; 82: 501-9.
42. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 2004; 36: 447-9.
43. Keller RB, Gagne KE, Usmani GN, Asdourian GK, Williams DA, Hofmann I etal. CTC1 mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer 2012; 59: 311-4.
44. Walne AJ, Vulliamy T, Kirwan M, Plagnol V, Dokal I. Constitutional mutations in RTEL1 cause severe dyskeratosis congenita. Am J Hum Genet 2013; 92: 448-53.
45. Vulliamy T, Beswick R, Kirwan M, Marrone A, Digweed M, Walne A etal. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A 2008; 105: 8073-78.
46. Walne AJ, Vulliamy T, Marrone A, Beswick R, Kirwan M, Masunari Y et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet 2007; 16: 1619-29.
47. Anderson BH, Kasher PR, Mayer J, Szynkiewicz M, Jenkinson EM, Bhaskar SS etal. Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet 2012; 44: 338-42.
48. Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med 2010; 12: 753-64.
49. Dokal I, Vulliamy T, Mason P, Bessler M. Clinical utility gene card for: dyskeratosis congenita. Eur J Hum Genet 2011; 19. doi:10.1038/ejhg.2011.90
50. Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007; 110: 1439-47.
51. Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M etal. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant 2013; 19: 1238-43.
52. Khincha PP, Wentzensen IM, Giri N, Alter BP, Savage SA. Response to androgen therapy in patients with dyskeratosis congenita. Br J Haematol 2014; 165: 349-57.
53. Silhan LL, Shah PD, Chambers DC, Snyder LD, Riise GC, Wagner CL etal. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur Respir J 2014; 44: 178-87.
54. Armanios M. Telomerase and idiopathic pulmonary fibrosis. Mutat Res 2012; 730: 52-8.
55. Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ etal. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005; 352: 1413-24.
56. Sakaguchi H, Nishio N, Hama A, Kawashima N, Wang X, Narita A etal. Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia. Haematologica 2014; 99: 1312-6.
57. Scheinberg P, Cooper JN, Sloand EM, Wu CO, Calado RT, Young NS. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA 2010; 304: 1358-64.